The acronym or ticker notation VOYG often references Voyager Therapeutics, Inc., a clinical-stage biotechnology enterprise traded publicly under the primary NASDAQ ticker symbol VYGR. The corporation focuses heavily on advancing innovative gene therapies and neurogenetic medicines designed to combat severe central nervous system disorders. Investors tracking this security monitor its clinical pipeline progress, collaborative agreements with major pharmaceutical partners, and quarterly financial disclosures to gauge its developmental trajectory within the biotechnology sector.